Sale!

Bordetella Pertussis RNA Detection Qualitative Test

Original price was: $170.Current price is: $144.

-15%

The Bordetella Pertussis RNA Detection Qualitative Test is a highly sensitive molecular diagnostic test that detects the genetic material of Bordetella pertussis bacteria, the primary cause of whooping cough. Using advanced Real-Time PCR technology, this test provides rapid and accurate identification of active pertussis infections, enabling timely treatment and preventing disease spread. The test analyzes nasopharyngeal secretions, swabs, and various respiratory samples to detect bacterial RNA with exceptional precision. Early detection is crucial for effective antibiotic therapy and reducing transmission risk, especially in vulnerable populations like infants and elderly individuals. This test is particularly valuable during pertussis outbreaks and for patients with persistent coughing symptoms. Results are typically available within 36-48 hours, providing healthcare providers with critical diagnostic information for appropriate patient management. The test costs $144 USD with our current discount, making advanced pertussis testing accessible and affordable.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Bordetella Pertussis RNA Detection Qualitative Test

Comprehensive Diagnostic Testing for Whooping Cough

The Bordetella Pertussis RNA Detection Qualitative Test represents a cutting-edge molecular diagnostic approach for identifying active pertussis infections, commonly known as whooping cough. This sophisticated test utilizes Real-Time Polymerase Chain Reaction (PCR) technology to detect the genetic material of Bordetella pertussis bacteria with exceptional sensitivity and specificity. Early and accurate diagnosis of pertussis is crucial for implementing appropriate treatment protocols, preventing disease transmission, and managing public health concerns effectively.

What This Test Measures and Detects

This advanced molecular test specifically targets and amplifies the RNA genetic material of Bordetella pertussis bacteria, providing definitive evidence of active infection. The test detects:

  • Presence of Bordetella pertussis bacterial RNA in respiratory samples
  • Active pertussis infection through genetic material identification
  • Specific bacterial sequences unique to Bordetella pertussis strains
  • Early-stage infections before antibody responses develop

Who Should Consider This Test

This diagnostic test is recommended for individuals experiencing symptoms suggestive of pertussis infection or those with known exposure to confirmed cases. Key candidates include:

  • Patients with persistent coughing lasting more than 2 weeks
  • Individuals experiencing characteristic “whooping” sounds during coughing episodes
  • Post-cough vomiting or gagging incidents
  • Cyanosis (bluish skin discoloration) following coughing spells
  • Infants and young children with respiratory distress
  • Healthcare workers and childcare providers with respiratory symptoms
  • Individuals with compromised immune systems showing respiratory symptoms
  • Patients during known pertussis outbreaks in communities

Clinical Benefits of Pertussis RNA Detection

Choosing the Bordetella Pertussis RNA Detection Test offers numerous advantages for both patients and healthcare providers:

  • Early Diagnosis: Detects infections during the initial catarrhal stage when treatment is most effective
  • High Accuracy: Real-Time PCR technology provides superior sensitivity compared to traditional culture methods
  • Rapid Results: Turnaround time of 36-48 hours enables prompt clinical decision-making
  • Infection Control: Early identification helps implement isolation measures to prevent disease spread
  • Treatment Guidance: Confirms diagnosis for appropriate antibiotic therapy initiation
  • Public Health Monitoring: Supports outbreak investigation and surveillance efforts

Understanding Your Test Results

Proper interpretation of your Bordetella Pertussis RNA Detection Test results is essential for appropriate medical management:

  • Positive Result: Indicates active Bordetella pertussis infection requiring immediate antibiotic treatment and isolation precautions
  • Negative Result: Suggests absence of detectable Bordetella pertussis RNA, though clinical correlation is necessary
  • Inconclusive Result: May require repeat testing or additional diagnostic evaluation

Always discuss your results with your healthcare provider for comprehensive interpretation and treatment recommendations based on your specific clinical presentation.

Test Pricing Information

Price Type Amount (USD)
Discount Price $144
Regular Price $170

Nationwide Testing Availability

We maintain comprehensive testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures accessible pertussis testing services for patients nationwide.

Book Your Test Today

Take proactive steps toward accurate pertussis diagnosis and effective treatment. Our experienced genetic specialists and advanced laboratory facilities ensure reliable testing results with rapid turnaround times. Contact us today to schedule your Bordetella Pertussis RNA Detection Qualitative Test and receive the diagnostic clarity you need for optimal health management.

Call or WhatsApp: +1(267) 388-9828 to book your test appointment or discuss your testing needs with our genetic counseling team.